Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
PHASE2
This phase II trial tests how well propranolol and pembrolizumab work to ca...
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
PHASE1
The purpose of this study is to determine the effect of LY2216684 on heart ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.